Cancer Research Meeting Calendar  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 69, 1109, February 1, 2009. Published Online First January 20, 2009;
doi: 10.1158/0008-5472.CAN-08-3381
© 2009 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
0008-5472.CAN-08-3381v1
69/3/1109    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Z.
Right arrow Articles by Thirman, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Z.
Right arrow Articles by Thirman, M. J.

Molecular Biology, Pathobiology, and Genetics

Consistent Deregulation of Gene Expression between Human and Murine MLL Rearrangement Leukemias

Zejuan Li1, Roger T. Luo1, Shuangli Mi1, Miao Sun1, Ping Chen1, Jingyue Bao2, Mary Beth Neilly1, Nimanthi Jayathilaka1, Deborah S. Johnson3, Lili Wang2, Catherine Lavau4, Yanming Zhang1, Charles Tseng3, Xiuqing Zhang2, Jian Wang2, Jun Yu2, Huanming Yang2, San Ming Wang5, Janet D. Rowley1, Jianjun Chen1 and Michael J. Thirman1

1 Department of Medicine, University of Chicago, Chicago, Illinois; 2 Beijing Genomics Institute, Chinese Academy of Sciences, Beijing, China; 3 Department of Biological Sciences, Purdue University Calumet, Hammond, Indiana; 4 CNRS UPR9051, IUH, Paris, France; and 5 Center for Functional Genomics, Division of Medical Genetics, Department of Medicine, ENH Research Institute, Northwestern University, Evanston, Illinois

Requests for reprints: J. Chen, J.D. Rowley, or M.J. Thirman, 5841 South Maryland Avenue, MC 2115, Chicago, IL 60637. E-mail: jchen{at}medicine.bsd.uchicago.edu, jrowley{at}medicine.bsd.uchicago.edu, or mthirman{at}medicine.bsd.uchicago.edu.

Key Words: MLL rearrangement leukemia • evolutionarily conservation • gene expression • gene ontology • DNA methylation

Important biological and pathologic properties are often conserved across species. Although several mouse leukemia models have been well established, the genes deregulated in both human and murine leukemia cells have not been studied systematically. We performed a serial analysis of gene expression in both human and murine MLL-ELL or MLL-ENL leukemia cells and identified 88 genes that seemed to be significantly deregulated in both types of leukemia cells, including 57 genes not reported previously as being deregulated in MLL-associated leukemias. These changes were validated by quantitative PCR. The most up-regulated genes include several HOX genes (e.g., HOX A5, HOXA9, and HOXA10) and MEIS1, which are the typical hallmark of MLL rearrangement leukemia. The most down-regulated genes include LTF, LCN2, MMP9, S100A8, S100A9, PADI4, TGFBI, and CYBB. Notably, the up-regulated genes are enriched in gene ontology terms, such as gene expression and transcription, whereas the down-regulated genes are enriched in signal transduction and apoptosis. We showed that the CpG islands of the down-regulated genes are hypermethylated. We also showed that seven individual microRNAs (miRNA) from the mir-17-92 cluster, which are overexpressed in human MLL rearrangement leukemias, are also consistently overexpressed in mouse MLL rearrangement leukemia cells. Nineteen possible targets of these miRNAs were identified, and two of them (i.e., APP and RASSF2) were confirmed further by luciferase reporter and mutagenesis assays. The identification and validation of consistent changes of gene expression in human and murine MLL rearrangement leukemias provide important insights into the genetic base for MLL-associated leukemogenesis. [Cancer Res 2009;69(3):OF1109–16]




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S.-L. Goh, Y. Looi, H. Shen, J. Fang, C. Bodner, M. Houle, A. C.-H. Ng, R. A. Screaton, and M. Featherstone
Transcriptional Activation by MEIS1A in Response to Protein Kinase A Signaling Requires the Transducers of Regulated CREB Family of CREB Co-activators
J. Biol. Chem., July 10, 2009; 284(28): 18904 - 18912.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
R. K. Slany
The molecular biology of mixed lineage leukemia
Haematologica, July 1, 2009; 94(7): 984 - 993.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.